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Pre-TCR Signaling and Inactivation of p53
Induces Crucial Cell Survival Pathways
in Pre-T Cells
1994; reviewed in Levelt and Eichmann, 1995; Fehling
and Von Boehmer, 1997). This pre-TCR is a multi-subunit
receptor complex consisting of a heterodimer of a con-
ventional TCRb chain and a nonrearranging pTa chain,
as well as noncovalently linked CD3 subunits (Groettrup
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et al., 1993; Saint-Ruf et al., 1994; Van Oers et al., 1995;The Netherlands Cancer Institute
reviewed in Borst et al., 1996; Malissen and Malissen,Antoni van Leeuwenhoek Huis
1996; Berger et al., 1997; Haks et al., 1998). ThymocytesPlesmanlaan 121
from mice that cannot produce an essential component1066 CX Amsterdam
of the pre-TCR (Mombaerts et al., 1992a, 1992b; ShinkaiThe Netherlands
et al., 1992; Liu et al., 1993; Love et al., 1993; Malissen
et al., 1993, 1995; Ohno et al., 1993; Fehling et al., 1995;
DeJarnette et al., 1998; Haks et al., 1998; Wang et al.,Summary
1998) are arrested at the CD442CD251 DN stage of their
developmental program (reviewed in Fehling and VonSignaling through the pre-TCR is essential for early
Boehmer, 1997; Haks et al., 1999).T cell development and is severely impaired in mice
Functioning of the pre-TCR critically depends on thelacking the CD3g chain of the pre-TCR. We here ad-
signal transduction capacity of the CD3 complex. Alldress the molecular mechanisms underlying this de-
CD3 subunits involved in the formation of a maturefect. Impaired pre-TCR signaling is shown to be asso-
TCRab-CD3 complex (CD3g, CD3d, CD3e, and CD3z)ciated with a profound increase in the number of
have now been demonstrated to also be present in theapoptotic CD42CD82 (DN) thymocytes. Introduction of
pre-TCR, and CD3g and CD3e perform essential func-p53 deficiency into CD3g-deficient mice completely
tions in this receptor complex (Liu et al., 1993; Love etreverses the cell survival defect in CD3g-deficient DN
al., 1993; Malissen et al., 1993, 1995; Ohno et al., 1993;thymocytes and rescues the block in pre-T cell differ-
Van Oers et al., 1995; Berger et al., 1997; Haks et al.,entiation. In addition, the CD41CD81 (DP) compart-
1998; DeJarnette et al., 1998; Wang et al., 1998). Signal-ment is expanded to its normal size. These findings
ing through the pre-TCR is associated with a complexsuggest that the pre-TCR regulates progression through
cluster of differentiation events including downregula-the DNA-damage checkpoint of the DN to DP transition
tion of CD25, induction of CD4 and CD8 expression, andby inactivating p53.
cell cycle entry followed by intense cell proliferation
(Hoffman et al., 1996; reviewed in Fehling and Von
Boehmer, 1997; Haks et al., 1999). In addition, furtherIntroduction
rearrangements at the TCRb locus are terminated, re-
sulting in allelic exclusion and ensuring the generationThe successive developmental stages of intrathymic T
of DP thymocytes with a single productive TCRb chaincell differentiation can be extraordinarily well defined
(Aifantis et al., 1997; Krotkova et al., 1997; Ardouin eton the basis of sequential loss and gain of cell surface
al., 1998).expression of a number of key markers (reviewed in
An important issue that still needs to be addressedFehling and Von Boehmer, 1997; Borst et al., 1996; Haks
is whether the primary role of the pre-TCR in early T cellet al., 1999). The most immature thymocytes reside
development is enabling or inductive. While it is clear
within the CD42CD82 double-negative (DN) population,
that pre-TCR derived signals trigger crucial cues for
comprising only about 1%±3% of all cells in the adult
further development, it is not clear whether the pre-TCR
thymus. This DN population can be further subdivided itself actually transmits differentiative signals or whether
into at least four distinct developmental stages that are it, by providing survival and/or expansion signals, allows
defined by the differential expression of CD25 (IL-2 re- differentiation steps triggered by other pathways to oc-
ceptor a chain), CD44 (Pgp-1), and CD117 (c-kit) (Wu et cur. Nevertheless, the signal transduction pathways
al., 1991, 1996b; Godfrey et al., 1993, 1994; Jacobs et used by the pre-TCR to control thymocyte differentiation
al., 1994; Wilson et al., 1994; Shortman and Wu, 1996). involve the activation of Src-protein tyrosine kinases
One of the first major checkpoints thymocytes encoun- (PTKs) (reviewed in Eichmann, 1998; Tybulewicz, 1998;
ter during their developmental program is the transition, Haks et al., 1999), and several lines of evidence have
within the CD1172 DN population, from the CD442 highlighted in particular the importance of the Src-family
CD251 to the CD442CD252 pre-T cell stage, and we PTK p56lck in pre-TCR signaling (Molina et al., 1992;
here address how that transition is regulated. Anderson et al., 1993; Levin et al., 1993; Mombaerts et
Only cells that produce a functional TCRb protein ex- al., 1994; Levelt et al., 1995; Wallace et al., 1995; Groves
pand and proceed from the CD442CD251 to the CD442 et al., 1996; Van Oers et al., 1996; Fehling et al., 1997;
CD252 DN stage. This process is referred to as ªb-selec- Schmedt et al., 1998). In addition, some suggestions
tionº and is mediated by the pre-TCR (Dudley et al., for the involvement of p53 in the transition from the DN
to the DP stage have been generated. The importance of
the p53 tumor suppressor gene as a regulator of the cell³ To whom correspondence should be addressed (e-mail: akru@
nki.nl). cycle and apoptosis in response to DNA damage arising
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from treatment with genotoxic mediators has been well
established. Transcriptional activation of the cyclin-
dependent kinase inhibitor p21waf-1/cip-1 appears to mediate
p53-induced growth arrest (El-Deiry et al., 1993; Harper
et al., 1993), and apoptosis is promoted by repressing
Bcl-2 and upregulating death genes such as Bax (Living-
stone et al., 1992; reviewed in Hunter, 1993; Miyashita
et al., 1994; Miyashita and Reed, 1995; Ko and Prives,
1996; White, 1996; Agarwal et al., 1998). Whether p53 also
plays a role in response to DNA damage arising under
physiological conditions, such as site-specific V(D)J re-
combination of the TCRb locus in T cell precursors, is
only beginning to be addressed. SCID 3 p53-deficient
mice are permissive for the generation of low numbers
of DP thymocytes, supporting the notion of a correlation
between inactivation of the p53 gene and progression
beyond the DN stage (Bogue et al., 1996; Guidos et
al., 1996; Nacht et al., 1996). Since p53 deficiency also
induces some DP thymocytes in RAG-deficient mice
(Jiang et al., 1996) (although at a much lower frequency
compared to SCID 3 p532/2 mice), while RAG-deficient
thymocytes do not undergo TCR gene rearrangements,
it is difficult to interpret these findings.
We here examine the role of the pre-TCR in sup-
pressing a dominant programmed cell death pathway
operating in DN thymocytes. First, we show that mice
lacking a CD3g chain have a pre-TCR signaling defect
and a survival defect at the DN stage of development.
We then investigated the possible influence of Bcl-2 and
p53 genes on promoting differentiation to the DP stage
and the survival potential of DN thymocytes that are
defective in pre-TCR-mediated signaling. Although trans-
genic Bcl-2 had no impact on exit from the CD442CD251
DN stage and transition to the DP compartment in mice
lacking a functional pre-TCR, loss of function of p53
restored pre-T cell development in such a setting. In
addition, DN thymocytes in mice lacking a functional
pre-TCR are rescued from apoptotic cell death when a Figure 1. DP Thymocytes of CD3g-Deficient Mice Display an Abnor-
p53 deficiency is introduced. These data implicate p53 mal Phenotype
as a candidate downstream target molecule of the pre- Electronically gated DP thymocytes from 6- to 8-week-old CD3g1/2
and CD3g2/2 mice were analyzed by three-parameter flow cytometryTCR signaling cascade.
for (A) cell surface expression of CD69-FITC, CD5-FITC, CD24-PE,
and CD25-Biotin plus SA-Tricolor (shaded areas) or an irrelevant
mAb (open areas) and (B) intracellular expression of TCRb-FITCResults
(shaded areas) or an irrelevant mAb (open areas).
In CD3g-Deficient Mice, Impaired Pre-T Cell
Development Is a Consequence of Defective
In heterozygous mice, this latter CD251 population com-Signaling through the Pre-TCR
prises only 1%±5% (Figure 1A). These data indicate thatTransition from the CD442CD251 to the CD442CD252
DP thymocytes in CD3g-deficient mice have been gener-DN stage of T cell development is under the control of
ated by aberrant signaling through the pre-TCR com-the pre-TCR and severely impaired in CD3g-deficient
plex. It should be noted that the DP thymocytes gener-mice, with only very few cells progressing to the DP
ated in the absence of CD3g do belong to the ab T celland SP stage (Haks et al., 1998; Figure 2A). We asked
lineage, since all DP thymocytes express high levels ofwhether the few DP cells that are generated reflect aber-
intracellular TCRb chains (Figure 1B). Importantly, therant signaling through the pre-TCR. In normal mice, thy-
percentage of CD69-positive DP thymocytes in CD3g-mocytes undergo a maturational program during the DN
deficient mice is reduced (z4% compared to z20% into DP transition that includes upregulation of CD5 and
CD3g1/2 mice), suggesting inefficient positive selectiondownregulation of CD24 (HSA) and CD25 (Hough et al.,
in the absence of CD3g.1994; reviewed in Fehling and Von Boehmer, 1997). In
To further address whether impaired progression be-CD3g-deficient mice, DP thymocytes express higher lev-
yond the DN stage is a consequence of defective pre-els of CD24, lower levels of CD5, and approximately
z55%±70% of the DP thymocytes still express CD25. TCR signaling in CD3g-deficient mice, mice transgenic
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Figure 2. Transgenic p56lck Can Rescue the
Defect at the Pre-T Cell Stage in the Absence
of CD3g
Flow cytometry analysis of thymocytes from
6- to 8-week-old CD3g1/2, CD3g1/2p56lck-TG,
CD3g2/2, and CD3g2/2p56lck-TG mice. (A) To-
tal thymocytes were monitored for the ex-
pression of CD4-PE versus CD8-Biotin plus
SA-Tricolor (top panel), while the expression
of CD44-PE versus CD25-Biotin plus SA-Tri-
color was analyzed within the CD42CD82 DN
thymocyte subset (bottom panel). The per-
centage of cells within each quadrant is indi-
cated. The absolute number of thymocytes
detected in the different genotypes is de-
picted above the corresponding dot display.
(B) Cell surface expression of TCRb-FITC
(shaded areas) or an irrelevant mAb (open
areas) on electronically gated CD4-PE/CD8-
Biotin plus SA-Tricolor DP thymocytes.
for constitutively active p56lck were crossed to CD3g- of CD3g, this effect of a constitutively active p56lck
transgene is still operational (Figure 2B), suggesting thatdeficient mice (Figure 2). It should be noted that aug-
mented expression of p56lck results in some thymic mat- at least in this setting induction of signals leading to
allelic exclusion is independent of CD3g. Taken to-urational abnormalities, in that increased expression of
p56lck delays thymocyte development (Abraham et al., gether, a catalytically active p56lck transgene can rescue
pre-T cell development in the absence of CD3g. This1991a). Nevertheless, introduction of a catalytically ac-
tive p56lck transgene into the CD3g mutant background indicates that the observed developmental block in
CD3g-deficient mice is primarily due to defective pre-restored the absolute number of thymocytes to wild-
type (WT) levels and accounted for an approximately TCR signaling.
500-fold expansion of the DP compartment (Figure 2A,
top panel). More detailed analysis of the DN subset Lack of Pre-TCR-Mediated Signaling Correlates
with Apoptotic Deathpresent in p56lck-transgenic CD3g2/2 mice by monitoring
for cell surface expression of CD44 and CD25 revealed A possible primary function that has been ascribed to
the pre-TCR is providing survival and/or expansion sig-that expression of a transgene encoding activated p56lck
in mice lacking CD3g completely restores the transition nals to DN thymocytes, allowing their differentiation to
DP thymocytes triggered by other pathways to occur.from the CD442CD251 to the CD442CD252 DN stage
(Figure 2A, bottom panel). A prediction based on this view is that DN thymocytes
derived from mice defective in pre-TCR-mediated sig-Another maturational event associated with signaling
through the pre-TCR is termination of further rearrange- naling would exhibit an increase in apoptotic cells. To
explore this possibility, DN thymocytes of CD3g1/2,ments of the TCRb genes, resulting in allelic exclusion
at the TCRb locus (Aifantis et al., 1997; Krotkova et al., CD3g2/2, RAG-12/2, and SCID mice were compared by
staining with both Annexin V and propidium iodide (PI),1997; Ardouin et al., 1998). It has been demonstrated
that activated p56lck inhibits V(D)J rearrangements, and, allowing discrimination of viable (Annexin V2, PI2), apo-
ptotic (Annexin V1, PI2), and secondary necrotic (Annexinas a consequence, a drastic reduction in DP thymocytes
expressing cell surface TCRb is observed in p56lck- V1, PI1) cells (Vermes et al., 1995). Indeed, almost all
(z95%) DN thymocytes derived from CD3g1/2 mice weretransgenic mice (Anderson et al., 1992). In the absence
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Figure 3. DN Thymocytes Defective in Pre-
TCR Signaling Display an Increased Number
of Apoptotic Cells
Electronically gated CD4-PE/CD8-APC DN
thymocytes from 6- to 8-week-old CD3g1/2,
CD3g2/2, RAG-12/2, and SCID mice were ana-
lyzed for the expression of Annexin V-FITC
versus PI by flow cytometry. The percentage
of cells within each quadrant is indicated.
alive, whereas a large proportion (z40%±55%) of DN A number of observations indicate that, although inac-
tivation of p53 rescues pre-T cell development in CD3g-thymocytes derived from pre-TCR signaling defective
CD3g2/2, RAG-12/2, and SCID mice displayed an apo- deficient mice, positive selection is not restored (Figures
4A, 4C, and 5C). First, expression of CD69 is normallyptotic phenotype (Figure 3). The correlation between
lack of pre-TCR signaling and decreased cell survival upregulated by DP thymocytes that have been positively
selected. In CD3g-deficient 3 p53-deficient mice, how-suggests that blocking apoptosis is an essential func-
tion of the pre-TCR in thymocyte differentiation. ever, an almost complete absence of CD69-positive DP
thymocytes can be noted (Figure 4C). In addition, only
very few SP thymocytes are generated in CD3g2/2p532/2Loss of Function of p53 Rescues the Pre-T Cell
Developmental Block Imposed mice, compared to control mice (Figures 4A and 5C),
indicating that positive selection is controlled by a p53-by the Absence of CD3g
Recently, the tumor suppressor gene product p53 has independent pathway.
Most importantly, comparison of the DN thymocytesbeen suggested to be involved in the transition from the
DN to the DP stage of thymocyte development (Bogue derived from CD3g2/2 and CD3g2/2p532/2 mice by stain-
ing with both Annexin V and PI revealed that inactivationet al., 1996; Guidos et al., 1996; Nacht et al., 1996). A
direct link between pre-TCR function and p53, however, of p53 significantly increased the percentage of viable
DN thymocytes from z55% to z95% (Figures 3 andremains to be established. To investigate this possibility,
CD3g-deficient mice that lack a functional pre-TCR were 4D). The number of viable DN cells in CD3g-deficient
mice thus becomes equivalent to the percentage of via-crossed to p53-deficient mice, to assess whether loss
of function of p53 can overcome the defect imposed by ble DN thymocytes found in control mice by introduction
of p53 deficiency. Only DN thymocytes that have pro-the absence of CD3g (Figure 4). Remarkably, inactivation
of p53 in the CD3g mutant background restored the duced a TCRb chain are rescued from apoptotic cell
death by loss of function of p53, since all DP thymocytesabsolute number of thymocytes to WT levels, induced
the efficient generation of DP thymocytes (Figure 4A), present in CD3g2/2p532/2 mice express high levels of
intracellular TCRb chains (Figure 4C). Taken together,and released the block at the CD442CD251 DN stage
(Figure 4B). Since the DP compartment now generated these data are in accordance with a model implicating
inactivation of p53 as a downstream event of pre-TCRdisplays a diverse Vb repertoire, as determined both by
flow cytometry (Figure 4E) and RT-PCR analysis using signaling.
Vb62 and Vb8-specific primers in combination with a
Jb2.5 primer (data not shown), it does not reflect forma- Besides Providing Survival Signals, the Pre-TCR
Provides Additional Differentiative Signalstion of tumors. In addition, the rescue imposed by p53
deficiency does not simply reflect more leakage to the Besides the established role of p53 as a regulator of
apoptosis (Livingstone et al., 1992; Miyashita et al., 1994;DP stage, since the DP thymocytes generated in CD3g2/2
p532/2 mice, at least with respect to the expression of Miyashita and Reed, 1995), p53 also features as a possi-
ble mediator of cell cycle arrest (El-Deiry et al., 1993;CD25, resemble DP thymocytes derived from heterozy-
gous control mice (Figures 1A and 4C). Harper et al., 1993). The present finding of a rescue of
Pre-TCR Signals: Survival and p53 Inactivation
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Figure 4. Inactivation of p53 Rescues the
Pre-T Cell Developmental Block Imposed by
the Absence of CD3g
(A) Total thymocytes from 6-week-old CD3g1/2,
CD3g1/2p532/2, CD3g2/2, and CD3g2/2p532/2
mice were monitored for the expression of
CD4-PE versus CD8-Biotin plus SA-Tricolor.
The percentage of cells within each quadrant
is indicated. The absolute number of thymo-
cytes detected in the different genotypes is
depicted above the corresponding dot display.
(B) Expression of CD44-PE versus CD25-Bio-
tin plus SA-Tricolor was analyzed within the
CD42CD82 DN thymocyte subset of the indi-
cated mice. The percentage of cells within
each quadrant is indicated.
(C) Electronically gated DP thymocytes from
CD3g1/2 and CD3g2/2p532/2 mice were ana-
lyzed by three-parameter flow cytometry for
cell surface expression of CD25-Biotin plus
SA-Tricolor and CD69-FITC (shaded areas)
and intracellular expression of TCRb-FITC
(shaded areas) or an irrelevant mAb (open
areas).
(D) Electronically gated CD4-PE/CD8-APC
DN thymocytes from CD3g1/2, CD3g2/2, and
CD3g2/2p532/2 mice were analyzed for the
expression of Annexin V-FITC versus PI by
flow cytometry. The percentage of cells
within each quadrant is indicated.
(E) Analysis of intracellular Vb chain expres-
sion on electronically gated DP thymocytes
from CD3g2/2p532/2 mice. The percentage of
positive cells is indicated.
development in mice lacking a functional pre-TCR by Together with the effects of p53 on cell survival (Figure
4D), the above findings document that the rescue ofintroduction of p53 deficiency could therefore also be
explained by an effect on expansion. To investigate pre-T cell development by p53 inactivation in pre-T cells
lacking CD3g is primarily a consequence of a releasewhether absence of CD3g inhibits cell cycle progres-
sion at the transition from the DN to the DP stage, the from an apoptotic pathway. We next asked whether yet
additional pre-TCR-induced signals are required for thecellular DNA content of CD442CD252 DN thymocytes
derived from CD3g1/2 and CD3g2/2 mice (Figure 5A) and DN to DP transition, and argued that a kinetic analysis
of the rescue imposed by loss of function of p53 wouldDP thymocytes derived from CD3g1/2, CD3g1/2p532/2,
CD3g2/2, and CD3g2/2p532/2 mice (Figure 5B) was ana- be informative in this regard. If p53 deficiency, by releas-
ing the apoptotic block, was required and sufficient forlyzed by staining with Hoechst 33342. In the CD442
CD252 DN subset as well as the DP compartment of triggering the DN to DP transition, its effect would be
immediate. Remarkably, however, the release of theCD3g1/2 and CD3g2/2 mice, a comparable percentage
of cycling cells (z2.5% in S phase and z5.5% in G2 1 pre-T cell development block in CD3g-deficient mice by
inactivation of p53 is a time-consuming event (FigureM phases) could be observed, indicating that cell cycle
progression is not affected by the aberrant signaling 5C). Comparison of total thymocytes of 10-day-, 3
week-, and 6-week-old CD3g2/2 and CD3g2/2p532/2through CD3g-deficient pre-TCRs (Figures 5A and 5B,
top panel). In addition, loss of function of p53 promotes mice showed that at 10 days of age, thymic cellularity
as well as the CD4/CD8 profile was indistinguishablecell cycle progression in CD3g1/2 as well as CD3g2/2
mice to a similar extent. Both mouse strains showed a between both genotypes (Figure 5C). Starting at 2±3
weeks of age, loss of function of p53 clearly results inreduction of cells in the G1/G0 phase of the cell cycle
and a relative increase in cells in S (z9%) and G2 1 M a progressive increase in the absolute cell number and
percentage of DP thymocytes in thymi derived from(z12%) compared to control mice (Figure 5B).
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Figure 5. CD3g2/2p532/2 Mice Display a Delay in the Generation of a Full-Size DP Compartment that Cannot be Ascribed to a Defect in Cell
Cycle Progression to the DP Stage
Cell cycle analysis of (A) CD442CD252 DN thymocytes from embryonic day 14 (E14) CD3g1/2 and CD3g2/2 mice or (B) CD8-FITC/CD4-PE DP
thymocytes from 6-week-old CD3g1/2, CD3g1/2p532/2, CD3g2/2, and CD3g2/2p532/2 mice by staining cellular DNA content using Hoechst
33342. The percentage of cells within the G1/G0 versus S and G2 1 M stages of the cell cycle is indicated.
(C) Total thymocytes from 10-day, 3-, and 6-week-old CD3g1/2, CD3g2/2, and CD3g2/2p532/2 mice were monitored for the expression of CD4-
PE versus CD8-Biotin plus SA-Tricolor. The percentage of cells within each quadrant is indicated. The absolute number of thymocytes detected
in the different genotypes at the different ages is depicted above each corresponding dot display.
CD3g2/2p532/2 mice, compared to CD3g2/2 mice. Ulti- mice transgenic for Bcl-2 (Figure 6B). Consistent with
these data, equivalent expression levels of intracellularmately, both parameters reach wild-type levels at 5±6
weeks of age (Figures 4A and 5C). The most likely expla- Bcl-2 were detected in DN thymocytes derived from
CD3g1/2, CD3g2/2, and RAG-12/2 mice, suggesting thatnation for these findings is that inactivation of p53, while
rescuing survival of CD3g-deficient pre-T cells, does not apoptosis of DN thymocytes in the absence of pre-TCR
signaling is not caused by reduced Bcl-2 expressionrescue other pre-TCR-induced developmental signals.
This strongly argues that the pre-TCR, besides providing levels (Figure 6C). In conclusion, these results suggest
that pre-TCR signaling blocks a pathway to apoptosiscrucial survival signals, provides additional differentia-
tive signals that can be separated from those regulating that is insensitive to Bcl-2.
cell cycle progression.
Discussion
Transgenic Bcl-2 Does Not Rescue Pre-T Cell
Development in CD3g-Deficient Mice Maturation of thymocyte precursors from the CD42
CD82 DN to the CD41CD81 DP stage of developmentSince the results outlined above document an essential
role for the pre-TCR in blocking apoptosis at the pre-T requires productive rearrangement of the gene seg-
ments encoding the TCRb chain (Dudley et al., 1994;cell stage, we next investigated whether Bcl-2, a pro-
tooncogene known to prolong cell survival by inhibiting Levelt and Eichmann, 1995; Hoffman et al., 1996; Fehling
and Von Boehmer, 1997). Whether a functional TCRbprogrammed cell death in response to a variety of apo-
ptotic stimuli (Korsmeyer, 1992; Oltvai and Korsmeyer, chain has been produced is assessed using the pre-
TCR complex. One of the components of this pre-TCR1994), may participate in the transition from the DN to
the DP stage. To address whether overexpression of complex is the CD3g chain, and mice lacking CD3g, due
to targeted gene disruption, display dramatic defects inBcl-2 can rescue pre-T cell development in the absence
of CD3g, Bcl-2-transgenic mice were crossed to CD3g- ab T cell development (Haks et al., 1998). The transition
from the CD442CD251 to the CD442CD252 DN stage,deficient mice (Figure 6). Expression of transgenic Bcl-2
had no effect on thymocyte development in mice lacking which is under the control of the pre-TCR, is severely
impaired in these mice, resulting in a reduction in theCD3g. Thymic cellularity as well as the CD4/CD8 profile
were comparable between nontransgenic and Bcl-2- number of DP and SP thymocytes and a concomitant
drastic reduction in total thymic cellularity (Haks et al.,transgenic CD3g2/2 mice (Figure 6A). Further analysis
of the expression of CD44 and CD25 in DN thymocytes 1998). Using these CD3g-deficient mice, we here ad-
dress which downstream effectors are involved in pre-revealed also that thymocyte differentiation remained
arrested at the CD442CD251 DN stage in CD3g-deficient TCR signaling.
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Figure 6. Transgenic Bcl-2 Does Not Rescue
Pre-T Cell Development in CD3g-Deficient
Mice
(A) Total thymocytes from 6- to 8-week-old
CD3g1/2, CD3g1/2Bcl-2-TG, CD3g2/2, and
CD3g2/2Bcl-2-TG mice were monitored for
the expression of CD4-PE versus CD8-Biotin
plus SA-Tricolor. The percentage of cells
within each quadrant is indicated. The abso-
lute number of thymocytes detected in the
different genotypes is depicted above the
corresponding dot display.
(B) Expression of CD44-PE versus CD25-
Biotin plus SA-Tricolor was analyzed within
the CD42CD82 DN thymocyte subset from
CD3g1/2, CD3g2/2, and CD3g2/2Bcl-2-TG
mice. The percentage of cells within each
quadrant is indicated.
(C) Expression of intracellular Bcl-2 (open ar-
eas) or an irrelevant mAb (shaded areas) was
analyzed in CD42CD82- DN thymocytes de-
rived from adult CD3g1/2 and CD3g2/2 mice
or embryonic day 14 (E14) CD3g1/2 (thin solid
line), CD3g2/2 (fat solid line), and RAG-12/2
(dotted line) mice.
Since we observed (Figure 3) that a large proportion et al., 1995; Hoffman et al., 1996), activation of p53 may
initially induce a growth arrest of pre-T cells. Presum-of DN thymocytes in CD3g-deficient mice have entered
apoptosis, we investigated the possible connection be- ably, in the event that a pre-T cell does not produce a
functional pre-TCR, p53 accumulates further as a conse-tween p53 and the pre-TCR defect of CD3g-deficient
mice. The transcription factor p53 plays a critical role quence of lack of pre-TCR signaling, and this ultimately
results in apoptosis. In support of this view, it has beenin controlling expression of genes that regulate cell cycle
arrest and apoptosis, and we postulated that it may also demonstrated that the nature of the effect of p53 (cell
cycle arrest versus apoptosis) in certain cell types isoperate in the control of pre-T cell development. A first
indication for a possible role of p53 in thymocyte devel- controlled in a quantitative manner (Chen et al., 1996).
Following productive TCRb rearrangements and com-opment came from the observation that p53-deficient
mice develop a high incidence of T cell lymphomas position of the pre-TCR, pre-TCR-mediated signaling
inactivates p53, resulting in a release from the apoptotic(Donehower et al., 1992; Purdie et al., 1994; reviewed
in Jacks, 1996; Almog and Rotter, 1997). We found that pathway, cell cycle entry, and differentiation. This hy-
pothesis is consistent with the finding that cells with aintroduction of the p53 deficiency by cross-breeding
into CD3g-deficient mice rescues DN cells from apo- functional pre-TCR induce activity of the mitotic kinase
complex p34cdc2 (Hoffman et al., 1996). Since phosphory-ptosis and releases the pre-T cell developmental block,
implicating p53 as a candidate downstream target mole- lation of p53 by p34cdc2 results in a dramatic reduction
of its half-life (Lin and Desiderio, 1993), pre-TCR signal-cule of the pre-TCR signaling cascade.
Our findings are consistent with a model (Figure 7) in ing can be predicted to result in p53 inactivation. In
agreement with this prediction, defective pre-TCR sig-which inactivation of p53 is placed downstream from
pre-TCR signaling. p53 has been demonstrated to be naling can be overcome by introduction of p53 defi-
ciency. Signaling through the pre-TCR may thus regulateinvolved in induction of growth arrest at the G0/G1 cell
cycle checkpoint in response to genotoxic agents that progression through the DNA-damage checkpoint of the
DN to DP transition by phosphorylating p53. It is clearcause DNA double-stranded breaks (DSBs) (reviewed
in Jacks, 1996). Since thymocytes undergoing V(D)J re- that subsequent expansion and differentiation signals
are then free to proceed, and one particular topic forcombination also slow down in cell proliferation (PeÂ nit
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by the dominant inhibitor of Bcl-2, Bax (Oltvai et al.,
1993; Yin et al., 1994; reviewed in Oltvai and Korsmeyer,
1994), the balance in Bcl-2-transgenic RAG-deficient mice
is somewhat in favor of Bcl-2. However, in CD3g-defi-
cient mice, there is presumably a more intense activation
of p53 and Bax in response to DSBs, and transgenic
Bcl-2 is unable to counter their proapoptotic effects.
Since a number of findings point toward a role for the
CD3 components as potential substrates and/or attach-
ment sites for p56lck in the pre-TCR, we also addressed
whether CD3g is required in this regard. Our data clearly
show that introduction of a constitutively active p56lck
transgene in CD3g-deficient mice efficiently restores
pre-T cell development, documenting that CD3g is not
required for proper function of p56lck in pre-TCR-medi-
ated signaling. These findings also exclude a mandatory
role for the CD3g-ITAM in recruitment of p56lck into the
pre-TCR complex. Consistent with these findings, we
previously found that the defect in pre-T cell develop-
ment in CD3g-deficient mice can be overcome by anti-
CD3e-mediated cross-linking (Haks et al., 1998), a phe-
nomenon that has been demonstrated to be largely
p56lck dependent (Levelt et al., 1995; Wu et al., 1996a).
In summary, the present study shows a complete res-
cue of the DN to DP transition by introduction of a p53
deficiency into a setting with a defined pre-TCR signal-
ing defect. Moreover, in such a setting p53 deficiency
rescues survival of DN thymocytes. Taken together,
Figure 7. Model for p53-Dependent Pre-TCR Signaling
these results provide strong evidence for the notion that
p53 inactivation is a crucial, pre-TCR triggered event in
early T cell development. In addition, the finding thatfuture research is to define the pathways that regulate
the DN to DP transition in p53-deficient mice with a pre-these events.
TCR signaling defect is a time-consuming event leadsConsistent with the view that activation of p53 may
us to conclude that the search for pre-TCR triggeredhave been triggered in response to DSBs resulting from
events is not over yet: clearly, additional differentiativesite-specific TCR gene recombinations occurring in
signals, only poorly generated by the CD3g-deficientearly pre-T cells, Western blot analysis of DN thymo-
pre-TCR studied here, are required for efficient differen-cytes derived from SCID mice revealed substantial
tiation to occur. Nevertheless, p53 inactivation is likelyamounts of p53 protein (Guidos et al., 1996). Introduc-
to represent the first step in the sequence of events thattion of the RAG mutation into the SCID background
accompanies the DN to DP transition.decreased the expression of p53 protein below detec-
tion level, demonstrating that activation of p53 in SCID
thymocytes requires RAG function (Guidos et al., 1996), Experimental Procedures
presumably because generation of DSBs is mediated
Miceby the RAG-1 and RAG-2 proteins. Nevertheless, some
Mice were maintained under specific pathogen-free conditions inrearrangement-independent activation of p53 may oc-
the animal colony of the Netherlands Cancer Institute and analyzed
cur in the thymus, as immunoprecipitates of thymocyte at 6 to 8 weeks old unless indicated otherwise. C.B-17 scid (SCID)
lysates from RAG-deficient mice did reveal low levels mice, mice deficient for CD3g, RAG-1, or p53, and Bcl-2-Ig
of p53 protein (Jiang et al., 1996), and introduction of transgenic mice have been described in detail elsewhere (Bosma
et al., 1983; McDonnell et al., 1989; Donehower et al., 1992; Mom-the p53 mutation into the RAG-deficient background is
baerts et al., 1992b; Haks et al., 1998).permissive for the development of some DP thymocytes
Constitutively active p56lck-transgenic mice were generated using(Jiang et al., 1996). The very fact that there is clearcut
the pLGF transgene described by Abraham et al. (1991a). Expression
apoptosis in the DN compartment of RAG-deficient of this transgene is directed by the thymus-specific p56lck proximal
mice, despite the very marginal p53 expression, sug- promoter. Transgene-positive animals were identified by hybridiza-
gests that also p53-independent apoptotic pathways tion to a probe derived from the human growth hormone 39 region
(Abraham et al., 1991a, 1991b). Transgenic lines were maintainedoperate at this stage. The low protein level of p53 in
by crossing transgenic-positive CD3g1/2 males to CD3g1/2 femaleRAG-deficient thymocytes, and therefore probably also
mice.of Bax, whose expression is positively regulated by p53
(Miyashita et al., 1994; Miyashita and Reed, 1995), may
Flow Cytometryexplain the observation that transgenic Bcl-2 does have
Preparation of samples for flow cytometry analysis was performedsome effect on pre-T cell development in RAG-deficient
as described (Haks et al., 1998). Cells were analyzed on a Becton-
mice (Linette et al., 1994), while transgenic Bcl-2 does Dickinson FACScan with lysis II software. Forward- and side-scatter
not affect pre-T cell development in CD3g-deficient mice gating and/or propidium iodide (PI) gating was used to exclude dead
cells from the analysis.(Figure 6). Since Bcl-2 survival signals can be countered
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For an intracellular staining, cells were first stained for cell surface Anderson, S.J., Abraham, K.M., Nakayama, T., Singer, A., and Perl-
mutter, R.M. (1992). Inhibition of T-cell receptor b-chain gene re-markers. Subsequently, cells were washed twice in PBA (1 3 PBS,
1% BSA, and 0.02% NaN3) containing 0.1% Saponin (Merck) and arrangement by overexpression of the non-receptor protein tyrosine
kinase p56lck. EMBO J. 11, 4877±4886.then incubated with mAb diluted in PBA containing 0.25% Saponin
for 20±30 min at 48C. Cells were washed twice in 100 ml of PBA Anderson, S.J., Levin, S.D., and Perlmutter, R.M. (1993). Protein
containing 0.1% Saponin and if applicable incubated with second- tyrosine kinase p56lck controls allelic exclusion of T-cell receptor
step reagent in PBA containing 0.25% Saponin. Finally, all cells b-chain genes. Nature 365, 552±554.
were washed twice and resuspended in 100 ml of PBA. Cells were Ardouin, L., Ismaili, J., Malissen, B., and Malissen, M. (1998). The
analyzed on a Becton-Dickinson FACSCalibur. CD3-gde and CD3-z/h modules are each essential for allelic exclu-
Biotinylated, FITC-, PE-, or APC-conjugated antibodies specific sion at the T cell receptor b locus but are both dispensable for the
for murine CD5 (clone 53-7.3), CD8a (clone 53-6.7), CD8b (clone 53- initiation of V to (D)J recombination at the T cell receptor-b, -g, and
5.8), CD24 (HSA; clone M1/69), CD25 (clone 7D4), CD44 (clone IM7), -d loci. J. Exp. Med. 187, 105±116.
CD69 (clone H1.2F3), TCRb (clone H57-597), Vb2 (clone B20.6), Vb3
Berger, M.A., DaveÂ , V., Rhodes, M.R., Bosma, G.C., Bosma, M.J.,(clone KJ25), Vb5.1,5.2 (clone MR9-4), Vb11 (clone RR3-15), and
Kappes, D.J., and Wiest, D.L. (1997). Subunit composition of pre-Tpurified hamster anti-mouse Bcl-2 (clone 3F11) were obtained from
cell receptor complexes expressed by primary thymocytes: CD3dPharMingen. R-PE anti-mouse CD4 (clone CT-CD4) was purchased
is physically associated but not functionally required. J. Exp. Med.from Caltag. Where appropriate, streptavidin (SA)-Tricolor (Caltag)
186, 1461±1467.or goat anti-hamster IgG-FITC (Caltag) were used as second-step
Bogue, M.A., Zhu, C., Aguilar-Cordova, E., Donehower, L.A., andreagents.
Roth, D.B. (1996). p53 is required for both radiation-induced differen-
tiation and rescue of V(D)J rearrangement in scid mouse thymo-
Apoptosis Assay cytes. Genes Dev. 10, 553±565.
Flow cytometry analysis of apoptotic cells was performed using Borst, J., Jacobs, H., and Brouns, G. (1996). Composition and func-
an APOPTEST-FITC kit according to the manufacturer's protocol tion of T-cell receptor and B-cell receptor complexes on precursor
(Nexins Research). In brief, after staining of the cells for cell surface lymphocytes. Curr. Opin. Immunol. 8, 181±190.
markers, cells were washed twice in PBA and resuspended in 13
Bosma, G.C., Custer, R.P., and Bosma, M.J. (1983). A severe com-binding buffer at 1 3 105 to 1 3 106 cells/ml. Annexin V-FITC and
bined immunodeficiency mutation in the mouse. Nature 301,PI (2.5 mg/ml final concentration) were added and incubated in the
527±530.dark for 10 min at 48C. Thereafter, cells were immediately analyzed
Chen, X., Ko, L.J., Jayaraman, L., and Prives, C. (1996). p53 levels,on a FACSCalibur.
functional domains, and DNA damage determine the extent of the
apoptotic response of tumor cells. Genes Dev. 10, 2438±2451.
Cell Cycle Analysis DeJarnette, J.B., Sommers, C.L., Huang, K., Woodside, K.J., Em-
Cellular DNA content was determined by Hoechst 33342 (Sigma) mons, R., Katz, K., Shores, E.W., and Love, P.E. (1998). Specific
staining. Total thymocytes were cell surface stained with FITC- and requirement for CD3e in T cell development. Proc. Natl. Acad. Sci.
PE-conjugated mAbs. Cells were then washed twice in 100 ml PBA USA 95, 14909±14914.
and fixed in PBS containing 1% paraformaldehyde (PFA) for 30 min
Donehower, L.A., Harvey, M., Slagle, B.L., McArthur, M.J., Mont-
at 48C. After washing twice in 100 ml PBA and once in 100 ml PBA
gomery, C.A., Jr., Butel, J.S., and Bradley, A. (1992). Mice deficient
containing 0.3% Saponin, cells were incubated with Hoechst 33342
for p53 are developmentally normal but susceptible to spontaneous
(10 mg/ml diluted in PBA containing 0.3% Saponin) for 30 min at
tumours. Nature 356, 215±221.
378C. Finally, cells were washed once in 100 ml PBA containing 0.3%
Dudley, E.C., Petrie, H.T., Shah, L.M., Owen, M.J., and Hayday, A.C.Saponin, resuspended in 100 ml PBA, and analyzed on a FACStarplus
(1994). T cell receptor b chain gene rearrangement and selectionusing an ultraviolet light source measuring blue fluorescence from
during thymocyte development in adult mice. Immunity 1, 83±93.Hoechst 33342 between 390 and 489 nM.
Eichmann, K. (1998). The Lck paradox: because of inconsistent ex-
perimental evidence, the role of the protein tyrosine kinase p56lck in
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